GM lays off thousands of EV workers amid slower adoption and regulatory changes, impacting production at key facilities.
Escaped rhesus macaques from overturned truck spark search and concerns over potential infections.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
GM lays off thousands of EV workers amid slower adoption and regulatory changes, impacting production at key facilities.
Escaped rhesus macaques from overturned truck spark search and concerns over potential infections.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.